Skip to main content

Table 1 Study participant information

From: Examining impairment and kinetic patterns associated with recent use of hemp-derived Δ8-tetrahydrocannabinol: case studies

Parameter

Subject 103

Subject 104

Subject 105

BMI (kg/m2)

31.9

25.7

32.3

Age (years)

25

25

23

Cannabis use

history (years)

10

10

10

Prior cannabis use

(# days/last 14 days)

14

14

14

Primary route of administration

Oral

Inhalation (vaporization)

Inhalation

(smoking)

Time since last

cannabis use (h)

16

24

12

Prior experience

with ∆8-THC

None

None

None

Baseline blood ∆9-THC (ng/mL)

1.8

4.1

4.9

Baseline breath ∆9-THC (pg/filter pad)

1,298

255

< LOQ

  1. BMI Body mass index, 8-THC8-tetrahydrocannabinol, 9-THC9-tetrahydrocannabinol, LOQ Limit of quantification (188 pg/filter pad)